These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 7222342)

  • 1. [Effect of hypotensive agents on prostaglandin-induced ocular hypertension].
    Ermakova VN
    Vestn Oftalmol; 1981; (1):11-2. PubMed ID: 7222342
    [No Abstract]   [Full Text] [Related]  

  • 2. Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.
    Andrés-Guerrero V; Alarma-Estrany P; Molina-Martínez IT; Peral A; Herrero-Vanrell R; Pintor J
    Exp Eye Res; 2009 Mar; 88(3):504-11. PubMed ID: 19056382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
    Shimmyo M
    Am J Ophthalmol; 2005 Jun; 139(6):1148; author reply 1148-9. PubMed ID: 15953471
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacology of dl-1-(4-hydroxyphenyl)-2-isopropylamino ethanol hydrochloride, an ocular hypotensive agent in rabbits.
    Leaders FE; Fortenberry BR; Chiang TS; Van Hoose MC
    Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):368-82. PubMed ID: 5575590
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of dicinone and taurine on the effects of prostaglandins].
    Bunin AIa; Ermakova VN; Shvarts GIa; Mashkovskiĭ MD
    Farmakol Toksikol; 1980; 43(3):356-8. PubMed ID: 7449979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences.
    Bean GW; Camras CB
    Surv Ophthalmol; 2008 Nov; 53 Suppl1():S69-84. PubMed ID: 19038626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
    Brandt JD; Beiser JA; Gordon MO; Kass MA;
    Am J Ophthalmol; 2004 Nov; 138(5):717-22. PubMed ID: 15531304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypotensive and miotic action of stabilized solutions of physostigmine and physostigmine-pilocarpine (experimental data)].
    Fauziia Saied AKh; Sporova NA; Kondrat'eva TS
    Vestn Oftalmol; 1978; (5):17-8. PubMed ID: 706040
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotensive effect of profilin on rabbit intraocular pressure.
    Morales M; Gómez-Cabrero A; Peral A; Gasull X; Pintor J
    Eur J Pharmacol; 2007 Jul; 567(1-2):145-8. PubMed ID: 17499235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accounting for restart rates in evaluating persistence with ocular hypotensives.
    Schwartz GF; Platt R; Reardon G; Mychaskiw MA
    Ophthalmology; 2007 Apr; 114(4):648-52. PubMed ID: 17398318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
    Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
    Bhattacherjee P; Williams BS; Paterson CA
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenine nucleotide effect on intraocular pressure: Involvement of the parasympathetic nervous system.
    Peral A; Gallar J; Pintor J
    Exp Eye Res; 2009 Jun; 89(1):63-70. PubMed ID: 19250934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular pressure response to medication in a clinical setting: the Marshfield Clinic Personalized Medicine Research Project.
    McCarty CA; Mukesh BN; Kitchner TE; Hubbard WC; Wilke RA; Burmester JK; Patchett RB
    J Glaucoma; 2008 Aug; 17(5):372-7. PubMed ID: 18703947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of topical diltiazem on the intraocular pressure in betamethasone-induced ocular hypertensive rabbits.
    Melena J; Santafé J; Segarra J
    J Pharmacol Exp Ther; 1998 Jan; 284(1):278-82. PubMed ID: 9435188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uniocular drug trials.
    Rotchford AP; King AJ
    Ophthalmology; 2004 Dec; 111(12):2315; author reply 2315-6. PubMed ID: 15582097
    [No Abstract]   [Full Text] [Related]  

  • 19. Latanoprost therapy in patients with glaucoma and ocular hypertension inadequately controlled with carteolol.
    Yasar T; Ozdemir M; Andi I; Ozdemir G; Simsek S
    Jpn J Ophthalmol; 2004; 48(2):172-3. PubMed ID: 15060799
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanisms of the hypotensive effect of dicinone on the intraocular pressure].
    Ermakova VN; Komlev NA; Bunin AIa
    Vestn Oftalmol; 1978; (3):11-4. PubMed ID: 685014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.